Citations

Showing 10 of 108162 citations.

Gut Microbiota Represent a Major Thermogenic Biomass
Riedl, Ruth A. , Burnett, Colin , Pearson, Nicole A, Reho, John J. , Mokadem, Mohamad , Edwards, Robert A. , Kirby, John R. , Grobe, Justin L. , Grobe, Justin L , Kindel, Tammy Lyn

Mayo Clinic

Function | April 16, 2021 | Volume: 2 | Issue: 3 | Pages: No page available

10.1093/function/zqab019 | PMID 33939772 Get It

Abstract Evidence supports various roles for microbial metabolites in the control of multiple aspects of host energy flux including feeding behaviors, digestive efficiency, and energy expenditure, but few studies have quantified the energy utilization of the biomass of the gut microbiota itself. Because gut microbiota exist in an anoxic environment, energy flux is expected to be anaerobic; unfortunately, commonly utilized O2/CO2 respirometry-based approaches are unable to detect anaerobic energy flux. To quantify the contribution of the gut microbial biomass to whole-animal energy flux, we examined the effect of surgical reduction of gut biomass in C57BL/6J mice via cecectomy and assessed energy expenditure using methods sensitive to anaerobic flux, including bomb and direct calorimetry. First, we determined that cecectomy caused an acceleration of weight gain over several months due to a reduction in combined total host plus microbial energy expenditure, as reflected by an increase in energy efficiency (ie, weight gained per calorie absorbed). Second, we determined that under general anesthesia, cecectomy caused immediate changes in heat dissipation that were significantly modified by short-term pretreatment with dietary or pharmaceutical interventions known to modify the microbiome, and confirmed that these effects were undetectable by respirometry. We conclude that while the cecum only contributes approximately 1% of body mass in the mouse, this organ contributes roughly 8% of total resting energy expenditure, that this contribution is predominantly anaerobic, and that the composition and abundance of the cecal microbial contents can significantly alter its contribution to energy flux.
Venlafaxine prescription claims among insured women of reproductive age and pregnant women, 2011–2016
Summers, April D. , Anderson, Kayla N. , Ailes, Elizabeth C. , Grosse, Scott D. , Tepper, Naomi K. , Reefhuis, Jennita , Bobo, William V. , Grosse, Scott D

Mayo Clinic

Birth Defects Research | April 16, 2021 | Volume: 113 | Issue: 14 | Pages: 1052-1056

10.1002/bdr2.1897 | PMID 33860984 Get It

AbstractBackgroundSome studies have reported associations between prenatal use of venlafaxine, a serotonin‐norepinephrine reuptake inhibitor used for depressive and anxiety disorders, and some birth defects. We described the prevalence of venlafaxine prescription claims among privately insured women of reproductive age and pregnant women.MethodsVenlafaxine prescription claims were examined using the IBM MarketScan Commercial Databases. We included women of reproductive age (15–44 years) who had ≤45 days of lapsed enrollment during the calendar year of interest (2011–2016) in a non‐capitated healthcare plan sponsored by a large, self‐insured employer with prescription drug coverage and no mental health service carve‐out. Annual cohorts of pregnant women were identified among eligible women of reproductive age via pregnancy diagnosis and procedure codes. Venlafaxine prescriptions were identified via National Drug Codes in outpatient pharmacy claims and we estimated the annual proportion of women with venlafaxine claims by pregnancy trimester (pregnant women only), age, and Census division.ResultsEach year during 2011–2016, approximately 1.2% of eligible reproductive‐aged and 0.3% of eligible pregnant women filled a venlafaxine prescription. Among pregnant women, the proportion with venlafaxine claims was highest during the first trimester and decreased during the second and third trimesters. Small temporal increases in venlafaxine claims were observed for reproductive‐aged and pregnant women, with the largest among women aged 15–19 years.ConclusionsVenlafaxine prescription claims were low among women of reproductive age and pregnant women during 2011–2016, with some increasing use over time among women aged 15–19 years.
Powering the brain in health and disease
Kozicz, Tamás , Yardeni, Tal , Kozicz, Tamas , Morava, Éva

Mayo Clinic

European Journal of Neuroscience | April 16, 2021 | Volume: 53 | Issue: 9 | Pages: 2943-2945

10.1111/ejn.15230 | PMID 33861478 Get It

Superficial Siderosis: A Clinical Review
Kumar, Neeraj

Mayo Clinic

Annals of Neurology | April 16, 2021 | Volume: 89 | Issue: 6 | Pages: 1068-1079

10.1002/ana.26083 | PMID 33860558 Get It

Superficial siderosis of the central nervous system results from subpial hemosiderin deposition due to chronic low‐grade bleeding into the subarachnoid space. The confluent and marginal subpial hemosiderin is best appreciated on iron‐sensitive magnetic resonance imaging sequences. With widespread use of magnetic resonance imaging, the disorder is increasingly being recognized, including in asymptomatic individuals. Gait ataxia, often with hearing impairment is a common clinical presentation. A clinical history of subarachnoid hemorrhage is generally not present. A macrovascular pathology is generally not causative. The most common etiology is dural disease, often dural tears. Prior or less commonly ongoing symptoms of craniospinal hypovolemia may be present. Common etiologies for dural tears include disc disease and trauma, including surgical trauma. Patients with dural tears due to herniated and calcified discs often have a ventral intraspinal fluid collection due to cerebrospinal fluid leak. A precise identification of the dural tear relies on multimodality imaging. It has been speculated that chronic bleeding from fragile blood vessels around the dural tear may be the likely underlying mechanism. Surgical correction of the bleeding source is a logical therapeutic strategy. Clinical outcomes are variable, although neuroimaging evidence of successful dural tear repair is noted. The currently available data regarding use of deferiprone in patients with superficial siderosis is insufficient to recommend its routine use in patients. ANN NEUROL 2021;89:1068–1079
Machine Learning and Artificial Intelligence in Neurosurgery: Status, Prospects, and Challenges
Dagi, T. Forcht , Barker, Fred G., Glass, Jacob L. , Dagi, T Forcht

Mayo Clinic

Neurosurgery | April 16, 2021 | Volume: 89 | Issue: 2 | Pages: 133-142

10.1093/neuros/nyab170 | PMID 34015816 Get It

Recognizing and Preventing Participant Deception in Online Nicotine and Tobacco Research Studies: Suggested Tactics and a Call to Action
Heffner, Jaimee L. , Watson, Noreen L , Dahne, Jennifer , Croghan, Ivana T. , Kelly, Megan M. , McClure, Jennifer B. , Bars, Matthew P, Thrul, Johannes , Meier, Eric , Meier, Eric N. , Croghan, Ivana, Meier, Eric

Mayo Clinic

Nicotine & Tobacco Research | April 16, 2021 | Volume: 23 | Issue: 10 | Pages: 1810-1812

10.1093/ntr/ntab077 | PMID 33876244 Get It

Nonoperative Management of Posterior Shoulder Instability: What Are the Long-Term Clinical Outcomes?
Lee, Julia, Bernard, Christopher D. , Leland, Devin P. , Keyt, Lucas K. , Krych, Aaron J. , Dahm, Diane L., Woodmass, Jarret M, Krych, Aaron J , Lee, Julia, Woodmass, Jarret Murray , Camp, Christopher L.

Mayo Clinic

Clinical Journal of Sport Medicine | April 16, 2021 | Volume: 32 | Issue: 2 | Pages: e116-e120

10.1097/jsm.0000000000000907 | PMID 33852434 Get It

Objective: To report the injury characteristics, radiographic findings, and long-term outcomes of nonoperative management for posterior shoulder instability (PSI). Design: A retrospective review of 143 patients with PSI using a large geographic database. Setting: Single county between January 1994 and July 2012. Patients: A clinical history and diagnosis of PSI, one confirmatory imaging study to support the diagnosis, and a minimum of 5 years follow-up were required for inclusion. Patients with seizure disorders, anterior-only instability, multidirectional instability, and superior labrum from anterior to posterior diagnosis were excluded. Interventions: Patients with PSI were managed nonoperatively or operatively. Main Outcome Measures: Pain, recurrent instability, and progression into glenohumeral osteoarthritis at long-term follow-up. Results: One hundred fifteen patients were identified. Thirty-seven (32%) underwent nonoperative management. Twenty (54%) patients were diagnosed with posterior subluxation, 3 (8%) with a single dislocation, and 7 (19%) with multiple dislocations. Symptomatic progression of glenohumeral arthritis was observed in 8% (3) of patients. Pain improved in 46% (17) of patients and worsened in 19% (7). Recurrent instability and progression to osteoarthritis occurred in 15% (3/20) of patients with a traumatic instability event compared with 0% of atraumatic patients after nonoperative management ( P = 0.234). Pain at follow-up was more common in nonoperative than operative patients ( P = 0.017). Conclusions: Nonoperative management is a viable option for many patients with posterior shoulder instability; however, many may continue to have posterior shoulder pain.
Anterior Petrosal Approach for Enlarging Previously Radiated Recurrent Trigeminal Schwannoma: 2-Dimensional Operative Video
Rinaldo, Lorenzo , Patel, Neil , Driscoll, Colin L. W., Link, Michael J.

Mayo Clinic

Operative Neurosurgery | April 16, 2021 | Volume: 20 | Issue: 5 | Pages: E353-E353

10.1093/ons/opaa418 | PMID 33438028 Get It

Abstract Trigeminal nerve schwannomas (TNSs) are rare lesions that typically present with symptoms of trigeminal neuropathy or other cranial nerve palsies. These lesions classically have a dumbbell shape, with an anterior component within Meckel's cave and posterior component extending into the posterior fossa through the porus trigeminus. Surgical resection of TNSs can often be achieved via an extradural subtemporal approach to Meckel's cave without an anterior petrousectomy, even for tumors with a significant posterior fossa component, as the tumor often erodes a portion of the petrous apex. 1 We present the case of a 53-yr-old female presenting to our institution with complete trigeminal neuropathy secondary to a right-sided, previously resected and radiated TNS. Serial imaging demonstrated an interval growth of significant residual tumor despite multiple adjuvant therapies, and, thus, the patient was recommended to undergo additional surgical resection. The lesion was approached through a right-sided subtemporal approach to Meckel's cave, 2 with a plan to utilize an anterior petrousectomy only if difficulty resecting the posterior fossa component of the tumor was encountered. Intraoperatively, the posterior fossa component was found to be densely adherent to the adjacent brainstem, likely secondary to prior surgery and radiation therapy, and, thus, an anterior petrousectomy was performed. Postoperatively, the patient had stable trigeminal neuropathy without any new neurological deficits and a magnetic resonance imaging (MRI) confirmed a gross total resection. In the accompanying video, we hope to demonstrate the steps and nuances of both the subtemporal approach to accessing Meckel's cave and anterior petrousectomy when employed for the resection of TNSs. The patient in question provided formal consent for the making of this video.
Neurology: Genetics Year in Review
Pandolfo, Massimo , Roos, Raymond, Milone, Margherita , Jayadev, Suman , Pulst, Stefan, Pulst, Stefan M.

Mayo Clinic

Neurology Genetics | April 16, 2021 | Volume: 7 | Issue: 1 | Pages: No page available

10.1212/nxg.0000000000000556 | PMID 33889725 Get It

Early Improvement in Clinical Status Following Ventricular Assist Device Implantation in Children: A Marker for Survival
Conway, Jennifer , Ravekes, William, McConnell, Patrick , Cantor, Ryan S. , Koehl, Devin, Sun, Benjamin , Daly, Richard C., Hsu, Daphne T. , Conway, Jennifer , Ravekes, William, McConnell, Patrick , Cantor, Ryan S. , Koehl, Devin, Sun, Benjamin C , Daly, Richard C., Hsu, Daphne T.

Mayo Clinic

ASAIO Journal | April 16, 2021 | Volume: 68 | Issue: 1 | Pages: 87-95

10.1097/mat.0000000000001420 | PMID 33852494 Get It

While clinical status at the time of ventricular assist device (VAD) implant can negatively affect outcomes, it is unclear if early improvement after implant can have a positive effect. Therefore, the objectives of this study were to describe the clinical status of pediatric patients supported with a VAD and determine the impact of clinical status on the 1-month follow-up form on survival and ability to discharge. This was a retrospective analysis of data collected prospectively by the Pediatric Interagency Registry for Mechanical Circulatory Support Registry (Pedimacs) Registry. The Pedimacs database was queried for patients implanted between September 19, 2012, and September 30, 2019, who were alive on VAD support at 1-month postimplant on either a paracorporeal pulsatile or intracorporeal continuous device. Four factors on the 1-month follow-up were the focus of this study: mechanical ventilation, supplemental nutritional support, inotropic support, and ambulatory status. These factors were regarded as present if detected between 1-week and 1-month postimplant and were analyzed to determine their impact on survival following 1 month of VAD support and on successful discharge from hospital in patients with implantable continuous-flow devices. The eligible study cohort consisted of 414 patients with a mean age of 9.6 ± 6.2 years, weight of 40.8 ± 32.3 kg with the majority being male (56.7%) and having cardiomyopathy (68%). An isolated left ventricular assist device (LVAD) was the most common implant (85.5%). At implant, 40% were ventilated, 57% required nutritional support, 93% were on inotropes, and 58% were nonambulating. On the 1-month postimplant form, there were significant improvements in all four categories (14% ventilator support, 46% nutritional support, 53% on inotropes, and 25% nonambulating). However, there was no significant early change in the percentage of patients requiring supplemental nutrition in the paracorporeal pulsatile devices (88% vs. 82%; p = 0.2). Presence of these clinical parameters in early follow-up postimplant had a significant negative impact on survival and on the ability of patients with continuous-flow devices to be discharged. Presence of four specific clinical parameters early after VAD placement is associated with worse overall survival and an inability to discharge patients on VAD support. Ongoing work is needed for optimization of patients before implant and aggressive rehabilitation after implant to help improve long-term outcomes.